Hidoc Updates

Hidoc Updates is a Bi-Weekly Medical and Marketing Newsletter from Hidoc Dr. Marketing Team

New Articles

Anti-HIV tablet is Safe for Young Gay and Bisexual Boys

7 September 2017 Hidoc Dr. 0

According to a new study, the young men who have sex with men can safely use the tablet that protects against the HIV.

Health Minister takes responsibility to concentrate on reducing dependence on medicines

6 September 2017 Hidoc Dr. 0

Health minister, Choubey, declared that improving awareness on public health and reducing people’s reliance on drugs will be high on his program.

Hospitals will pay if consulting Doctors involved in Medical Carelessness

4 September 2017 Hidoc Dr. 0

Shakila Banu had a fall seven years ago, used to get back pain while sitting for over 3 hours at a stretch. She was admitted […]

Doctors are soft targets!

4 September 2017 Hidoc Dr. 0

IMA president Dr. KK Agrawal stated that Doctors are soft targets and should not be sent to jail for doing their job.

Swine flu takes 1100 lives in India in 2017

2 September 2017 Hidoc Dr. 0

Based on a report Swine Flu has taken 1100 lives in India. 448 cases have been reported in Maharashtra that seems to be worst affected.

FDA Granted that Patients can Perform Hemodialysis at Home

1 September 2017 Hidoc Dr. 0

It is the first of its kind approval that gives people a new level of independence from clinics and at home carers.

JP Nadda: It’s Essential for all under 30 to Cancer Screening

31 August 2017 Hidoc Dr. 0

J P Nadda, Union health minister disclosed that the Union government has chosen for an early recognition and the complete screening of Cancer.

Studies show that Ibuprofen can be toxic for arthritis patients

31 August 2017 Hidoc Dr. 0

Based on a report in Asian Age, Ibuprofen can increase the risk of heart disease, stroke, and high blood pressure in arthritis patients.

Key takeaways from the Draft Pharma Policy 2017 & How does it impact you?

31 August 2017 Hidoc Dr. 0

Hidoc brings to you key takeaways from the Draft Pharma Policy 2017 that includes generic drug, medical practioner, and price control policies.

Breakthrough CANCER therapy that works on re-engineered T Cells receives approval!

31 August 2017 Hidoc Dr. 0

Wednesday was a historic day for Cancer treatment with Novartis announcing FDA approval of Kymriah suspension for intravenous fusion or known as CAR-T.

Posts navigation

« 1 … 14 15 16 17 »
Loading

Recent Posts

  • New Cancer Therapy: FDA grants priority review of glofitamab for lymphoma
  • New Cancer Therapy: Whole-Tumor Cell Culture Can Predict Drug Response in Breast Cancer
  • Global Healthcare trends: WHO meets with Chinese officials on current COVID-19 situation
  • Healthcare trends 2022: Immune Suppression Impacts Risk for Breakthrough Infection after COVID-19 Vaccination
  • Healthcare trends 2022: India on alert for new variants as COVID wave sweeps China

Archives

  • January 2023
  • December 2022
  • November 2022
  • November 2019
  • October 2019
  • September 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017

Categories

  • Health Tips
  • Healthcare Digital Marketing
  • Medical Advice
  • New Articles
Loading
Search
Hidoc Dr. Footer

Infedis Infotech LLP,
Office 108, Suyog Center, Gultekdi,
Pune, 411040, India
varun@hidoc.co | 1800-202-5091

  • Instagram
  • LinkedIn
  • Facebook
  • YouTube

Copyright © 2023 | WordPress Theme by MH Themes